Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-014701
Filing Date
2023-08-14
Accepted
2023-08-14 07:30:59
Documents
62
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q armp-20230630x10q.htm   iXBRL 10-Q 1216517
2 EX-31.1 armp-20230630xex31d1.htm EX-31.1 15789
3 EX-31.2 armp-20230630xex31d2.htm EX-31.2 15294
4 EX-32.1 armp-20230630xex32d1.htm EX-32.1 8033
5 EX-32.2 armp-20230630xex32d2.htm EX-32.2 8226
6 GRAPHIC armp-20230630x10q001.jpg GRAPHIC 41517
  Complete submission text file 0001558370-23-014701.txt   5020556

Data Files

Seq Description Document Type Size
7 EX-101.SCH armp-20230630.xsd EX-101.SCH 37086
8 EX-101.CAL armp-20230630_cal.xml EX-101.CAL 33349
9 EX-101.DEF armp-20230630_def.xml EX-101.DEF 150228
10 EX-101.LAB armp-20230630_lab.xml EX-101.LAB 278245
11 EX-101.PRE armp-20230630_pre.xml EX-101.PRE 255695
56 EXTRACTED XBRL INSTANCE DOCUMENT armp-20230630x10q_htm.xml XML 744878
Mailing Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292
Business Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

EIN.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37544 | Film No.: 231166269
SIC: 2836 Biological Products, (No Diagnostic Substances)